A number of drugs were investigated involving amlodipine maleate tablets, anti-inflammatory and cholagogic tablets

▍ source: Anhui Provincial Drug Administration, Jiangsu Provincial Drug Administration ▍ sorting out: Cypress blue - drugstore Manager Two provinces notice, and 53 batches of drugs do not meet the requirements, drug supervision and prosecution according to the law, involving Amlodipi-ne Maleate Tablets, ningxinbao capsules, Triamcinolone Acetonide Nasal Spray, nine taste novice pills, Xiaoyan Li Dan tablets, Zheng Chaihu Yin granules On December 24, Anhui Provincial Food and Drug Administration issued the 4th drug quality announcement in 2019 According to the Anhui provincial drug sampling plan, the provincial market supervision and administration departments and drug inspection institutions at all levels have carried out supervision and sampling inspection on the drug quality of drug production, trading enterprises and users in their respective administrative regions, the announcement said According to the announcement, through sampling inspection and verification, 12 batches of 11 varieties of drugs do not meet the requirements of the standard, and the items that do not meet the requirements include [character], [inspection] difference in loading, total ash, water, aflatoxin, microbial limit and [content determination] The market supervision and administration departments at all levels are investigating and punishing the drugs and relevant units whose sampling results do not conform to the standards On December 23, Jiangsu Provincial Food and Drug Administration issued the third notice on drug quality in 2019 According to the annual sampling work plan of Jiangsu drug administration, it organized the sampling inspection of drug production, operation and use units, the circular said 41 batches of non-conforming drugs found in the spot check are hereby notified The bureau pointed out that for drugs that do not meet the requirements, the provincial drug regulatory departments at all levels have required relevant enterprises and units to investigate the causes of non-compliance and implement rectification on the basis of taking risk control measures such as suspension of sales and use The drug regulatory departments at all levels of our province have organized and carried out the investigation and punishment of relevant enterprises and units according to law.